Last reviewed · How we verify
NCT05485870
Early Screening and Identification for Panvascular Diseases
trial in Panvascular Diseases in 1,000 participants. Status unknown.
31 July 2024
Quick facts
| Lead sponsor | Beijing Tiantan Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 1,000 |
| Start date | 1 July 2022 |
| Primary completion | 31 July 2024 |
| Estimated completion | 31 December 2024 |
| Sites | 1 location across China |
Conditions studied
- Panvascular Diseases — all drugs for Panvascular Diseases →
Sponsor
Beijing Tiantan Hospital
Who can join
Eligibility, any sex, with Panvascular Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Identify the pathogenic factors involved in the occurrence and development of panvascular disease and its pathogenesis.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Circulating immune cell landscape and T-cell abnormalities in patients with moyamoya disease.
Ge P, Tao C, Wang W, He Q, et al · · 2024 · cited 21× · PMID 38566524 · DOI 10.1002/ctm2.1647 -
The intraoperative hemodynamic and clinical research of three direct bypasses in moyamoya disease a prospective cohort of 98 cases.
Shi Z, Wu L, Li W, Wang J, et al · · 2025 · cited 1× · PMID 40830192 · DOI 10.1038/s41598-025-15654-w -
Unraveling the Dyslipidemic Landscape in Moyamoya Disease: OxLDL as a Key Biomarker.
Zeng C, Chen H, Liu J, Bao Y, et al · · 2025 · PMID 40365738 · DOI 10.1111/cns.70441
Verify or expand the search:
- PubMed search for NCT05485870
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Panvascular Diseases
Currently open trials in the same condition.
- NCT07151183 — Diagnosis, Prognosis, and Mechanisms in Panvascular Disease · recruiting
Other Beijing Tiantan Hospital trials
Trials by the same sponsor.
- NCT07341854 — Dexamethasone Palmitate for Postoperative Pain · NA · not yet recruiting
- NCT07527013 — Stratified Blood Pressure Management Strategy After Endovascular Treatment for Acute Ischemic Stroke · Phase 3 · not yet recruiting
- NCT07520370 — Effect of Perioperative Ulinastatin on Postoperative Stroke in Patients With Brain Tumor · NA · not yet recruiting
- NCT07526987 — Efficacy and Safety of Minocycline in Patients With Acute Ischaemic Stroke Receiving Intravenous Thrombolysis · Phase 3 · not yet recruiting
- NCT07591207 — The Efficacy and Safety of Loxoprofen Sodium Patch in Relieving Postoperative Pain After Laparoscopic Surgery · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05485870 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Beijing Tiantan Hospital
- Last refreshed: 3 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05485870.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing